Ashland Launches Gafchromic™ In-Vivo Dosimetry System

WILMINGTON, Del., February 14, 2025, – Ashland, a premier specialty materials company, and leader in gafchromic™ film based advanced dosimetry solutions, is pleased to announce the launch of its in-vivo dosimetry system, designed to support treatment accuracy in radiation therapy. This innovative system is intended for use as a quality control system as a secondary verification of the radiation dose. This system allows for near real-time reporting of radiation doses delivered to patients during treatment. 

The gafchromic™ in-vivo dosimetry system utilizes advanced film technology that provides clinicians with feedback on the dose received by the patient.

key features of the gafchromic™ in-vivo dosimetry system:

• High Sensitivity and Accuracy: Single Pnt-Dos™ device suited for accurate measurements in both low & high doses.
• User-Friendly Interface: The intuitive updated filmQA pro Pnt-Dos™ software module makes it easy for clinicians to access and interpret dosimetry data, facilitating informed decision-making.
• Versatile Applications: Suitable for various types of radiation therapy applications.

"We are proud to introduce the gafchromic™ in-vivo dosimetry system, which represents a significant advancement in patient care," said Anandh Viswanathan, business leader, Diagnostic Films, Ashland. “Our commitment to innovation in radiation therapy helps by ensuring that healthcare providers can deliver the most effective treatments possible. We are elevating radiation therapy to an art form, where precision meets passion in the pursuit of healing.”

The gafchromic™ in-vivo dosimetry system is now available for clinical use. For more information, please click here.

About Gafchromic™ Films

Gafchromic™ films provide dosimetry solutions, dedicated to help improving patient safety and treatment efficacy in radiation therapy. With a focus on innovation and quality, gafchromic™ films supports healthcare professionals in delivering the highest standard of care.

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 3,200 passionate, tenacious solvers thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com  and ashland.com/ESG to learn more. 

™ Trademark, Ashland or its subsidiaries, registered in various countries.

Media Relations:
Deirdre Swinden
+1 (484) 678-7577
deirdre.swinden@ashland.com